Transcription factors and asthma

Asthma is characterized by the expression of multiple genes for inflammatory proteins, such as cytokines, enzymes, receptors and adhesion molecules. This is orchestrated by transcription factors, which are proteins that bind to the promoter regions of these genes and may be activated by inflammatory stimuli, such as cytokines. Several transcription factors are involved in asthmatic inflammation, including nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1), nuclear factor of activated T-cells (NF-AT), cyclic AMP response element binding protein (CREB) and signal transduction-activated transcription factors (STAT). These transcription factors lead to coordinated expression of multiple inflammatory genes. There is increasing evidence that synergistic interaction of these transcription factors (e.g. NF-kappaB and AP-1) results in the optimal expression of particular genes, resulting in the specific inflammatory pattern seen in asthmatic airways. Transcription factors are a target for antiasthma therapy. Corticosteroids activate glucocorticoid receptors, which themselves are transcription factors, and interact with other transcription factors to inhibit their actions. The interaction between transcription factors may be important in amplifying and inhibiting the inflammatory process. Many transcription factors interact with a large co-activator molecule CREB-binding protein (CBP) that coordinates the activation of several transcription factors and controls transcription through the regulation of deoxyribonucleic acid coiling around histone residues in the chromatin structure. Understanding transcription factors in asthma has given new insights into the complex chronic inflammatory process, the mechanism of action of corticosteroids, and may lead to new approaches to therapy in the future.

This article has been cited by other articles:

				D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease Eur. Heart J., February 1, 2009; 30(3): 266 - 277. [Abstract] [Full Text] [PDF]

				E. Boncoeur, T. Roque, E. Bonvin, V. Saint-Criq, M. Bonora, A. Clement, O. Tabary, A. Henrion-Caude, and J. Jacquot Cystic Fibrosis Transmembrane Conductance Regulator Controls Lung Proteasomal Degradation and Nuclear Factor-{kappa}B Activity in Conditions of Oxidative Stress Am. J. Pathol., May 1, 2008; 172(5): 1184 - 1194. [Abstract] [Full Text] [PDF]

				C. Thompson, A. Cloutier, Y. Bosse, C. Poisson, P. Larivee, P. P. McDonald, J. Stankova, and M. Rola-Pleszczynski Signaling by the Cysteinyl-Leukotriene Receptor 2: INVOLVEMENT IN CHEMOKINE GENE TRANSCRIPTION J. Biol. Chem., January 25, 2008; 283(4): 1974 - 1984. [Abstract] [Full Text] [PDF]

				A. Panebra, M. R. Schwarb, C. B. Glinka, and S. B. Liggett Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L453 - L462. [Abstract] [Full Text] [PDF]

				W. M. Abraham, A. Ahmed, I. Serebriakov, I. T. Lauredo, J. Bassuk, J. A. Adams, and M. A. Sackner Whole-Body Periodic Acceleration Modifies Experimental Asthma in Sheep Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 743 - 752. [Abstract] [Full Text] [PDF]

				P. Borger, M. Tamm, J. L. Black, and M. Roth Asthma: Is It Due to an Abnormal Airway Smooth Muscle Cell? Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 367 - 372. [Abstract] [Full Text] [PDF]

				P. J. Barnes Corticosteroid effects on cell signalling Eur. Respir. J., February 1, 2006; 27(2): 413 - 426. [Abstract] [Full Text] [PDF]

				S. L. Johnston and R. J. Martin Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis? Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1078 - 1089. [Abstract] [Full Text] [PDF]

				K. De Bosscher, W. V. Berghe, I. M. E. Beck, W. Van Molle, N. Hennuyer, J. Hapgood, C. Libert, B. Staels, A. Louw, and G. Haegeman A fully dissociated compound of plant origin for inflammatory gene repression PNAS, November 1, 2005; 102(44): 15827 - 15832. [Abstract] [Full Text] [PDF]

				T. Rhen and J. A. Cidlowski Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N. Engl. J. Med., October 20, 2005; 353(16): 1711 - 1723. [Full Text] [PDF]

				O. S. Usmani, K. Ito, K. Maneechotesuwan, M. Ito, M. Johnson, P. J. Barnes, and I. M. Adcock Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 704 - 712. [Abstract] [Full Text] [PDF]

				C. Desmet, P. Gosset, E. Henry, V. Garze, P. Faisca, N. Vos, F. Jaspar, D. Melotte, B. Lambrecht, D. Desmecht, et al. Treatment of Experimental Asthma by Decoy-mediated Local Inhibition of Activator Protein-1 Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 671 - 678. [Abstract] [Full Text] [PDF]

				P. Joubert, S. Lajoie-Kadoch, I. Labonte, A. S. Gounni, K. Maghni, V. Wellemans, J. Chakir, M. Laviolette, Q. Hamid, and B. Lamkhioued CCR3 Expression and Function in Asthmatic Airway Smooth Muscle Cells J. Immunol., August 15, 2005; 175(4): 2702 - 2708. [Abstract] [Full Text] [PDF]

				A. Lorentz, M. Wilke, G. Sellge, H. Worthmann, J. Klempnauer, M. P. Manns, and S. C. Bischoff IL-4-Induced Priming of Human Intestinal Mast Cells for Enhanced Survival and Th2 Cytokine Generation Is Reversible and Associated with Increased Activity of ERK1/2 and c-Fos J. Immunol., June 1, 2005; 174(11): 6751 - 6756. [Abstract] [Full Text] [PDF]

				E. A. Kirchner, G. Mols, G. Hermle, J. D. Muehlschlegel, K. K. Geiger, J. Guttmann, and H. L. Pahl Reduced activation of immunomodulatory transcription factors during positive end-expiratory pressure adjustment based on volume-dependent compliance in isolated perfused rabbit lungs Br. J. Anaesth., April 1, 2005; 94(4): 530 - 535. [Abstract] [Full Text] [PDF]

				P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF]

				X. Baur and L. Barbinova Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers Eur. Respir. J., February 1, 2005; 25(2): 309 - 316. [Abstract] [Full Text] [PDF]

				I. M. Adcock, K. Ito, and P. J. Barnes Glucocorticoids: Effects on Gene Transcription Proceedings of the ATS, November 1, 2004; 1(3): 247 - 254. [Abstract] [Full Text] [PDF]

				A.T. Dinh-Xuan and R. Naeije The hepatopulmonary syndrome: NO way out? Eur. Respir. J., May 1, 2004; 23(5): 661 - 662. [Full Text] [PDF]

				S. D. Message and S. L. Johnston Host defense function of the airway epithelium in health and disease: clinical background J. Leukoc. Biol., January 1, 2004; 75(1): 5 - 17. [Abstract] [Full Text] [PDF]

				E. R. McFadden Jr. Acute Severe Asthma Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759. [Abstract] [Full Text] [PDF]

				P. J. Barnes and I. M. Adcock How Do Corticosteroids Work in Asthma? Ann Intern Med, September 2, 2003; 139(5_Part_1): 359 - 370. [Full Text] [PDF]

				K. Ma, C. Mallidis, S. Bhasin, V. Mahabadi, J. Artaza, N. Gonzalez-Cadavid, J. Arias, and B. Salehian Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E363 - E371. [Abstract] [Full Text] [PDF]

				M. B. Hock and M. A. Brown Nuclear Factor of Activated T Cells 2 Transactivation in Mast Cells: A NOVEL ISOFORM-SPECIFIC TRANSACTIVATION DOMAIN CONFERS UNIQUE Fc{epsilon}RI RESPONSIVENESS J. Biol. Chem., July 11, 2003; 278(29): 26695 - 26703. [Abstract] [Full Text] [PDF]

				T.L. Ediger, N.A. Schulte, T.J. Murphy, and M.L. Toews Transcription factor activation and mitogenic synergism in airway smooth muscle cells Eur. Respir. J., May 1, 2003; 21(5): 759 - 769. [Abstract] [Full Text] [PDF]

				I. Jibiki, S. Hashimoto, S. Maruoka, Y. Gon, A. Matsuzawa, H. Nishitoh, H. Ichijo, and T. Horie Apoptosis Signal-Regulating Kinase 1-Mediated Signaling Pathway Regulates Nitric Oxide-Induced Activator Protein-1 Activation in Human Bronchial Epithelial Cells Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 856 - 861. [Abstract] [Full Text] [PDF]

				C.-D. Huang, O. Tliba, R. A. Panettieri Jr., and Y. Amrani Bradykinin Induces Interleukin-6 Production in Human Airway Smooth Muscle Cells: Modulation by Th2 Cytokines and Dexamethasone Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 330 - 338. [Abstract] [Full Text] [PDF]

				C. Nguyen, J.-L. Teo, A. Matsuda, M. Eguchi, E. Y. Chi, W. R. Henderson Jr., and M. Kahn Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma PNAS, February 4, 2003; 100(3): 1169 - 1173. [Abstract] [Full Text] [PDF]

				F Blasi, S Damato, R Cosentini, P Tarsia, R Raccanelli, S Centanni, and L Allegra Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment Thorax, August 1, 2002; 57(8): 672 - 676. [Abstract] [Full Text] [PDF]

				K. Parameswaran, L. J. Janssen, and P. M. O'Byrne Airway Hyperresponsiveness and Calcium Handling by Smooth Muscle : A "Deeper Look" Chest, February 1, 2002; 121(2): 621 - 624. [Abstract] [Full Text] [PDF]

				H. Carlsen, J. O. Moskaug, S. H. Fromm, and R. Blomhoff In Vivo Imaging of NF-{kappa}B Activity J. Immunol., February 1, 2002; 168(3): 1441 - 1446. [Abstract] [Full Text] [PDF]

				M. Singer, J. Lefort, and B. B. Vargaftig Granulocyte Depletion and Dexamethasone Differentially Modulate Airways Hyperreactivity, Inflammation, Mucus Accumulation, and Secretion Induced by rmIL-13 or Antigen Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 74 - 84. [Abstract] [Full Text] [PDF]

				S.D. Message and S.L. Johnston The immunology of virus infection in asthma Eur. Respir. J., December 1, 2001; 18(6): 1013 - 1025. [Abstract] [Full Text] [PDF]

				Y. Chen, Y. H. Zhao, Y.-P. Di, and R. Wu Characterization of Human Mucin 5B Gene Expression in Airway Epithelium and the Genomic Clone of the Amino-Terminal and 5'-Flanking Region Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 542 - 553. [Abstract] [Full Text] [PDF]

				M. O. Aksoy, W. Bin, Y. Yang, D. Yun-You, and S. G. Kelsen Nuclear factor-kappa B augments beta 2-adrenergic receptor expression in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1271 - L1278. [Abstract] [Full Text] [PDF]

				J. C. KIPS and R. A. PAUWELS Long-acting Inhaled beta 2-Agonist Therapy in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 923 - 932. [Full Text] [PDF]

				G. Caramori, S. Lim, K. Ito, K. Tomita, T. Oates, E. Jazrawi, K.F. Chung, P.J. Barnes, and I.M. Adcock Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies Eur. Respir. J., September 1, 2001; 18(3): 466 - 473. [Abstract] [Full Text] [PDF]

				S.H. Korn, A. Jerre, and R. Brattsand Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells Eur. Respir. J., June 1, 2001; 17(6): 1070 - 1077. [Abstract] [Full Text] [PDF]

				R.-F. Guo, A. B. Lentsch, R. L. Warner, M. Huber-Lang, J. V. Sarma, T. Hlaing, M. M. Shi, N. W. Lukacs, and P. A. Ward Regulatory Effects of Eotaxin on Acute Lung Inflammatory Injury J. Immunol., April 15, 2001; 166(8): 5208 - 5218. [Abstract] [Full Text] [PDF]

				B. G. Nichols, J. S. Woods, D. L. Luchtel, J. Corral, and J. Q. Koenig Effects of Ozone Exposure on Nuclear Factor-{{kappa}}B Activation and Tumor Necrosis Factor-{{alpha}} Expression in Human Nasal Epithelial Cells Toxicol. Sci., April 1, 2001; 60(2): 356 - 362. [Abstract] [Full Text] [PDF]

				W. W. Busse and R. F. Lemanske Asthma N. Engl. J. Med., February 1, 2001; 344(5): 350 - 362. [Full Text] [PDF]

				F. Bureau, S. Delhalle, G. Bonizzi, L. Fievez, S. Dogne, N. Kirschvink, A. Vanderplasschen, M.-P. Merville, V. Bours, and P. Lekeux Mechanisms of Persistent NF-{kappa}B Activity in the Bronchi of an Animal Model of Asthma J. Immunol., November 15, 2000; 165(10): 5822 - 5830. [Abstract] [Full Text] [PDF]

				K. Ito, P. J. Barnes, and I. M. Adcock Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1beta -Induced Histone H4 Acetylation on Lysines 8 and 12 Mol. Cell. Biol., September 15, 2000; 20(18): 6891 - 6903. [Abstract] [Full Text]

				S. McKay, S. J. Hirst, M. B.-d. Haas, J. C. de Jongste, H. C. Hoogsteden, P. R. Saxena, and H. S. Sharma Tumor Necrosis Factor-alpha Enhances mRNA Expression and Secretion of Interleukin-6 in Cultured Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 103 - 111. [Abstract] [Full Text]

				F. BUREAU, G. BONIZZI, N. KIRSCHVINK, S. DELHALLE, D. DESMECHT, M.-P. MERVILLE, V. BOURS, and P. LEKEUX Correlation between Nuclear Factor-kappa B Activity in Bronchial Brushing Samples and Lung Dysfunction in an Animal Model of Asthma Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1314 - 1321. [Abstract] [Full Text]

				S. Kruse, J. Forster, J. Kuehr, and K. A. Deichmann Characterization of the membrane-bound and a soluble form of human IL-4 receptor {alpha} produced by alternative splicing Int. Immunol., December 1, 1999; 11(12): 1965 - 1970. [Abstract] [Full Text] [PDF]

				L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF]

				K. Ito, E. Jazrawi, B. Cosio, P. J. Barnes, and I. M. Adcock p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids. MIFEPRISTONE FAILS TO RECRUIT HDAC2 TO THE p65-HAT COMPLEX J. Biol. Chem., August 3, 2001; 276(32): 30208 - 30215. [Abstract] [Full Text] [PDF]